It has been years since I first started digging into Dalton's/Univec's syringe business, but back when I first invested in UNVC, I found the following which suggests Univec does indeed still have the syringe business (or at least it did back at his time).
UNIVECÂs INFLU-JECT Safety Syringe Available in Preparation For Fall Flu Season
Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) today announced that its INFLU-JECT safety syringe, designed exclusively for immunizations requiring a 0.5cc dosage such as influenza and pneumonia, is now available. The product comes equipped with a 23-gauge, l-inch or 25-gauge 5/8-inch needle. The 1cc syringes are faster and easier to fill and take up less space than other immunization syringes.
(PRWEB) MAY 19, 2002
FARMINGDALE, N.Y. - May 17, 2002 - Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) today announced that its INFLU-JECT safety syringe, designed exclusively for immunizations requiring a 0.5cc dosage such as influenza and pneumonia, is now available. The product comes equipped with a 23-gauge, l-inch or 25-gauge 5/8-inch needle. The 1cc syringes are faster and easier to fill and take up less space than other immunization syringes. According to Pat Harper, RN and member of the Visiting Nurses Association, the Univec INFLU-JECT syringe  is easy to read, easy to use, and there is virtually no wasted, dead space. The Univec patented sliding sheath mechanism complies with OSHA regulations by engaging with only one hand to effectively reduce the risk of accidental needlesticks.
According to Dr. David L. Dalton, UnivecÂs President and CEO, the Univec INFLU-JECT Safety Syringe was specifically designed to facilitate delivery of flu and pneumonia vaccines. ÂWe believe it makes far more sense to deliver 0.5cc vaccine doses with a 1cc syringe rather than using larger, unnecessary sizes. The new Univec INFLU-JECT Safety Syringe provides the advantage of both practical size and compliance with OSHA needlestick safety requirements to protect patients and healthcare workers.Â
Leading health experts have documented that traditional disposable syringes are the leading cause for the spread of blood-borne pathogens such as HIV/AIDS and Hepatitis. Federal guidelines mandate the use of syringes equipped with a needlestick safety mechanism, including those used for vaccine programs.
About Univec
Founded in 1992, Univec is a leading manufacturer of patented auto-disable and safety syringes, medical waste disposal technology and pharmaceutical product promotion programs. The Company has global production facilities and has licensed its technology to Terumo of Belgium; a subsidiary of Terumo Japan, the leading producer of syringes outside the U.S. Univec distributes its products in 80 countries.
Forward Looking Statements
This document contains forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in UnivecÂs business. These risks and uncertainties include, but are not limited to, the risks described from time to time in UnivecÂs reports to the Securities and Exchange Commission. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in UnivecÂs reports filed with the SEC.
Contact:
G. Edward Kalbaugh
Allegent Growth Strategies International
516-364-7034 or e-mail gekalbaugh@allegentgsi.com
https://www.prweb.com/releases/2002/05/prweb38856.htm
UNIVECÂs INFLU-JECT Safety Syringe Available in Preparation For Fall Flu Season
Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) today announced that its INFLU-JECT safety syringe, designed exclusively for immunizations requiring a 0.5cc dosage such as influenza and pneumonia, is now available. The product comes equipped with a 23-gauge, l-inch or 25-gauge 5/8-inch needle. The 1cc syringes are faster and easier to fill and take up less space than other immunization syringes.
(PRWEB) MAY 19, 2002
FARMINGDALE, N.Y. - May 17, 2002 - Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) today announced that its INFLU-JECT safety syringe, designed exclusively for immunizations requiring a 0.5cc dosage such as influenza and pneumonia, is now available. The product comes equipped with a 23-gauge, l-inch or 25-gauge 5/8-inch needle. The 1cc syringes are faster and easier to fill and take up less space than other immunization syringes. According to Pat Harper, RN and member of the Visiting Nurses Association, the Univec INFLU-JECT syringe  is easy to read, easy to use, and there is virtually no wasted, dead space. The Univec patented sliding sheath mechanism complies with OSHA regulations by engaging with only one hand to effectively reduce the risk of accidental needlesticks.
According to Dr. David L. Dalton, UnivecÂs President and CEO, the Univec INFLU-JECT Safety Syringe was specifically designed to facilitate delivery of flu and pneumonia vaccines. ÂWe believe it makes far more sense to deliver 0.5cc vaccine doses with a 1cc syringe rather than using larger, unnecessary sizes. The new Univec INFLU-JECT Safety Syringe provides the advantage of both practical size and compliance with OSHA needlestick safety requirements to protect patients and healthcare workers.Â
Leading health experts have documented that traditional disposable syringes are the leading cause for the spread of blood-borne pathogens such as HIV/AIDS and Hepatitis. Federal guidelines mandate the use of syringes equipped with a needlestick safety mechanism, including those used for vaccine programs.
About Univec
Founded in 1992, Univec is a leading manufacturer of patented auto-disable and safety syringes, medical waste disposal technology and pharmaceutical product promotion programs. The Company has global production facilities and has licensed its technology to Terumo of Belgium; a subsidiary of Terumo Japan, the leading producer of syringes outside the U.S. Univec distributes its products in 80 countries.
Forward Looking Statements
This document contains forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in UnivecÂs business. These risks and uncertainties include, but are not limited to, the risks described from time to time in UnivecÂs reports to the Securities and Exchange Commission. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in UnivecÂs reports filed with the SEC.
Contact:
G. Edward Kalbaugh
Allegent Growth Strategies International
516-364-7034 or e-mail gekalbaugh@allegentgsi.com
https://www.prweb.com/releases/2002/05/prweb38856.htm
4
